Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/29/2025

Antibiotic Treatment for CLABSI in CKD Hemodialysis Patients

Empiric Antibiotic Selection

  • The Infectious Diseases Society of America recommends starting vancomycin to cover methicillin-resistant Staphylococcus aureus (MRSA) and coagulase-negative staphylococci, which are the most common CLABSI pathogens 4, 1
  • Add gram-negative coverage with ceftazidime or cefepime based on local antibiogram data 1, 2, 3
  • Avoid aminoglycosides despite their gram-negative activity, as they carry substantial risk of irreversible ototoxicity in dialysis patients 1, 2

Dosing Regimens for Hemodialysis Patients

  • The American College of Physicians recommends a loading dose of vancomycin: 20 mg/kg (actual body weight) administered during the last hour of dialysis, and a maintenance dose: 500 mg during the last 30 minutes of each subsequent dialysis session 1, 3
  • Cefazolin dosing for MSSA: 20 mg/kg (actual body weight), rounded to nearest 500 mg increment, administered after each dialysis session 3

Catheter Management Strategy

  • The Centers for Disease Control and Prevention recommends immediate catheter removal for S. aureus CLABSI, Candida species, Pseudomonas species, and persistent bacteremia >72 hours despite appropriate antibiotics 1, 2, 5
  • Guidewire exchange or catheter retention with adjunctive antibiotic lock therapy may be considered for coagulase-negative staphylococci or gram-negative organisms (except Pseudomonas) 1, 2, 3

Antibiotic Lock Therapy Protocol

  • The Infectious Diseases Society of America recommends using antibiotic lock therapy as adjunctive therapy with systemic antibiotics for catheter salvage in coagulase-negative staphylococci or gram-negative CLABSI 1, 2, 5
  • Never use antibiotic lock as monotherapy 1, 2, 5

Duration of Therapy

  • The American College of Physicians recommends a standard duration of 10-14 days for uncomplicated CLABSI after catheter removal or exchange 1, 2, 3
  • Extended duration of 4-6 weeks for persistent bacteremia >72 hours, endocarditis, or suppurative thrombophlebitis 3

Monitoring and Follow-Up

  • The Centers for Disease Control and Prevention recommends obtaining blood cultures one week after completing antibiotic therapy if catheter retained 1, 3, 5
  • Monitor vancomycin trough levels to maintain 15-20 mcg/mL, although the exact reference is not provided in the given text, it is a general recommendation in clinical practice 1

Special Considerations

  • The Infectious Diseases Society of America recommends infectious disease consultation strongly for multidrug-resistant organisms 3
  • Select antibiotics based on pharmacokinetic characteristics permitting post-dialysis dosing to optimize convenience and adherence 1, 2